• ქართული
  • English
  • Eli Lilly backs U.S. proposal on drug rebates to lower costs

    Eli Lilly and Co on Wednesday embraced a U.S. government proposal to end a decades-old system of rebates drugmakers make to industry middlemen, saying it could lower the cost of insulin and other prescription drugs for patients.

    Market Quotes by TradingView